Clearmind Signs Development and Supply Agreement to Produce Its Drug Candidate MEAI Psychedelic Molecule With Aragen Life Sciences
26 oct. 2021 08h00 HE
|
Clearmind Medicine
TORONTO, Ontario, Oct. 26, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – Clearmind Medicine Inc. (CSE: CMND, FSE: CWY0), (“Clearmind” or the "Company"), a psychedelic medicine biotech company focused...
Clearmind Medicine to Host ‘Psychedelics for Alcoholism‘ Virtual Educational Event on October 20
01 oct. 2021 08h00 HE
|
Clearmind Medicine
TORONTO, Oct. 01, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – Clearmind Medicine Inc. (CSE: CMND) (“Clearmind” or the "Company"), a psychedelic medicine biotech company focused on the discovery and...
Novamind to Present at Life Sciences Investor Forum
15 sept. 2021 08h35 HE
|
Life Sciences Investor Forum
TORONTO, Sept. 15, 2021 (GLOBE NEWSWIRE) -- Novamind Inc. (CSE: NM | OTCQB: NVMDF | FSE: HN2) (“Novamind” or the “Company”), a leading mental health company specialized in psychedelic medicine, is...
Microdose Psychedelic Insights Presents the Upcoming DMT Conference, a Deep Dive Into the Dynamic Field of DMT Therapeutics
30 août 2021 09h35 HE
|
Microdose Psychedelic Insights
NEW YORK, Aug. 30, 2021 (GLOBE NEWSWIRE) -- via NetworkNewsWire -- Microdose Psychedelic Insights, a cutting-edge media company focused on promoting content, financial analysis, and engaging events...
Microdose Psychedelic Insights to Host Psychedelic Capital Conference this Month
13 août 2021 09h35 HE
|
Microdose Psychedelic Insights
NEW YORK, Aug. 13, 2021 (GLOBE NEWSWIRE) -- via NetworkNewsWire -- -- Microdose Psychedelic Insights is a cutting-edge media company focused on creating compelling content, distributing financial...
Mindset Pharma Announces Promising Test Results of its Novel and Proprietary Psilocybin-Inspired Compounds
31 août 2020 07h00 HE
|
Mindset Pharma Inc.
TORONTO, Aug. 31, 2020 (GLOBE NEWSWIRE) -- Mindset Pharma ("Mindset"), a leading drug discovery and development business focused on next-generation psychedelic medicines to treat neuropsychiatric...
PSYC Continuing Its Path of Becoming Content Leader in The Psychedelic Space Through Key Interviews
25 août 2020 08h30 HE
|
Global Trac Solutions, Inc.
LAS VEGAS, Aug. 25, 2020 (GLOBE NEWSWIRE) -- Global Trac Solutions, Inc. (OTCPink: PSYC) (“Global” “PSYC” or the “Company”) is pleased to announce that as the Company continues to ramp-up efforts...
U.S. Small Cap Stocks Could Outperform The Market During The Recovery And Here Are Four Stocks You Need To Know About
22 juil. 2020 07h00 HE
|
OTC Stock Review
ATLANTA, July 22, 2020 (GLOBE NEWSWIRE) -- According to Premier Miton Fund Manager Nick Ford in a recent CNBC’s “Squawk Box Europe” interviewi, U.S. small cap stocks are set to outperform the...
North Sur Resources and Mindset Pharma Announce Proposed Transaction to Accelerate Development of Medical Psychedelics Industry
29 juin 2020 16h15 HE
|
Mindset Pharma Inc.
VANCOUVER, British Columbia, June 29, 2020 (GLOBE NEWSWIRE) -- North Sur Resources Inc. (“North Sur”) and Mindset Pharma Inc. (“Mindset”) are pleased to announce that they have signed a binding...
PSYC Primed for Launch During Covid-19
21 avr. 2020 08h30 HE
|
Global Trac Solutions, Inc.
Las Vegas, NV, April 21, 2020 (GLOBE NEWSWIRE) -- Global Trac Solutions, Inc. (OTCPink: PSYC) (“Global” “PSYC” or the “Company”) is pleased to announce they have engaged with a variety of key...